PROBIOTIX HEALTH LS-05 (F:X90) — Stock Price

€0.08 EUR
▲ 15.22% today

PROBIOTIX HEALTH LS-05 (F:X90) is currently trading at €0.08 EUR, up 15.22% today. Over the past 52 weeks, shares have ranged between €0.05 and €0.08. This page tracks PROBIOTIX HEALTH LS-05's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PROBIOTIX HEALTH LS-05 market capitalisation.

PROBIOTIX HEALTH LS-05 (X90) Stock Price Chart — Daily History & Trading Volume

The chart below tracks PROBIOTIX HEALTH LS-05's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

PROBIOTIX HEALTH LS-05 Income Statement — Revenue, Profit & Earnings by Year

PROBIOTIX HEALTH LS-05's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023
Total Revenue €1.88 Million €1.67 Million
Cost of Revenue €886.00K €801.00K
Gross Profit €997.00K €872.00K
Research & Development €28.00K €31.00K
SG&A €838.00K €727.00K
Total Operating Expenses €2.72 Million €2.39 Million
Operating Income €-839.00K €-719.00K
EBITDA
EBIT
Interest Expense
Income Before Tax €-852.00K €-762.00K
Income Tax Expense
Net Income €-847.00K €-747.00K

PROBIOTIX HEALTH LS-05 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes PROBIOTIX HEALTH LS-05's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 202420232022
Total Assets €2.18 Million €2.17 Million €2.34 Million
Total Current Assets €1.93 Million €1.87 Million €2.02 Million
Cash & Equivalents
Short-term Investments
Net Receivables €141.00K €203.00K €351.79K
Inventory €31.00K €103.00K €43.42K
Property, Plant & Equipment
Goodwill
Total Liabilities €254.00K €641.00K €350.91K
Total Current Liabilities €194.00K €566.00K €272.04K
Long-term Debt
Net Debt
Total Stockholder Equity €1.92 Million €1.53 Million €1.99 Million
Retained Earnings €-1.79 Million €-980.00K €-190.52K

PROBIOTIX HEALTH LS-05 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how PROBIOTIX HEALTH LS-05 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 202420232022
Operating Cash Flow €-1.06 Million €-238.00K €-638.02K
Capital Expenditures €10.00K €0.00 €46.08K
Free Cash Flow €-1.07 Million €-238.00K €-684.09K
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation €26.00K €33.00K
Depreciation €53.00K €53.00K €32.79K
Change in Cash €144.00K €-238.00K €1.54 Million

PROBIOTIX HEALTH LS-05 Earnings History — EPS Actual vs. Analyst Estimates

Track PROBIOTIX HEALTH LS-05's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Sep 08, 2025 0.00 0.00
May 29, 2025 0.00 0.00
Aug 30, 2024 0.00 0.00